| Model Number |
8637-40 |
| Medical Device Problem Code |
Infusion or Flow Problem (2964)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
05/20/2025
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Continuation of d10: product id 8578 lot# hg2axu509 implanted: (b)(6) 2018, explanted: (b)(6) 2025.Product type catheter section d information references the main component of the system.Other relevant device(s) are: product id: 8578, (b)(6), ubd: 06-feb-2020, (b)(4).Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
Information was received from the healthcare provider (hcp) via the company representative (rep) regarding a patient receiving intrathecal morphine 25mg/ml at 4.196mg/day via an implantable pump.It was reported there were no signs and symptoms reported.The catheter access port (cap) chamber was aspirated without success.New pump segment was added.This was found during routine pump replacement.The issue had not yet resolved at the time of this report.
|
| |
|
Event or Problem Description
|
|
Additional information was received from a healthcare provider (hcp) via a company representative (rep) and it was reported that the event was resolved by placing a new 8780 catheter.The entire catheter was replaced.
|
| |
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|